Jump Financial »

Kyverna Therapeutics shares owned by Jump Financial

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Jump Financial from 13F filings

Historical chart of Jump Financial investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Jump Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Jump Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $755k 80k 9.40
2024-06-30 $505k 67k 7.54

More positions owned by Jump Financial

iShares Russell 2000 ETF Etf (IWM)
SPDR S&P 500 ETF Trust Etf Call Option (SPY)
iShares 20 Year Treasury Bond ETF Etf (TLT)
NVIDIA Corp Common Stock (NVDA)
Walmart Common Stock (WMT)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
iShares iBoxx $ High Yield Corporate Bond ETF Etf (HYG)
Alphabet Common Stock (GOOGL)
Advanced Micro Devices Common Stock (AMD)
Netflix Common Stock (NFLX)
Palantir Technologies Common Stock (PLTR)
Alibaba Group Holding Convertible bond (Principal)
Boston Scientific Corp Common Stock (BSX)
Energy Transfer Partnership Shares (ET)

View all positions for Jump Financial

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
AIGH Capital Management
Insight Holdings
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
RFG Advisory
Susquehanna International

View all funds holding Kyverna Therapeutics